Wird geladen...
Considerations for using potential surrogate endpoints in cancer screening trials
The requirement of large-scale expensive cancer screening trials spanning decades creates considerable barriers to the development, commercialisation, and implementation of novel screening tests. One way to address these problems is to use surrogate endpoints for the ultimate endpoint of interest, c...
Gespeichert in:
| Veröffentlicht in: | Lancet Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2024
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7616115/ https://ncbi.nlm.nih.gov/pubmed/38697164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(24)00015-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|